MOLLY GARBER: Open Payments
NPI 1871979823 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 14 payments from 5 companies in 2025. Trend: 2023 $432 · 2024 $513 · 2025 $678
Food & beverage: $579Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $269 |
| ABBVIE INC. | 6 | $145 |
| Phathom Pharmaceuticals, Inc. | 1 | $122 |
| Madrigal Pharmaceuticals | 1 | $95 |
| GENZYME CORPORATION | 1 | $47 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, REZDIFFRA, DUPIXENT, CREON, LINZESS.
Industry payments across IA — which companies pay providers there.
